$2.00
0.00% yesterday
Nasdaq, Sep 03, 10:00 pm CET
ISIN
US88331L1089
Symbol
SKIN

Beauty Health Company (The) - Ordinary Shares - Class A Stock price

$2.00
+0.40 25.00% 1M
+0.73 56.86% 6M
+0.41 25.79% YTD
+0.29 16.96% 1Y
-9.48 82.58% 3Y
-8.84 81.55% 5Y
-8.84 81.55% 10Y
-8.84 81.55% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
+0.00 0.00%
ISIN
US88331L1089
Symbol
SKIN

Key metrics

Basic
Market capitalization
$253.7m
Enterprise Value
$404.8m
Net debt
$151.1m
Cash
$212.0m
Shares outstanding
126.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.8 | 0.8
EV/Sales
1.3 | 1.4
EV/FCF
12.0
P/B
3.4
Financial Health
Equity Ratio
7.6%
Return on Equity
-56.2%
ROCE
-9.7%
ROIC
-16.7%
Debt/Equity
4.9
Financials (TTM | estimate)
Revenue
$310.1m | $299.2m
EBITDA
$-20.2m | $20.6m
EBIT
$-43.4m | $-33.9m
Net Income
$-19.0m | $-19.7m
Free Cash Flow
$33.8m
Growth (TTM | estimate)
Revenue
-15.3% | -10.5%
EBITDA
63.6% | 300.2%
EBIT
50.6% | 14.7%
Net Income
77.3% | 32.5%
Free Cash Flow
599.7%
Margin (TTM | estimate)
Gross
63.2%
EBITDA
-6.5% | 6.9%
EBIT
-14.0%
Net
-6.1% | -6.6%
Free Cash Flow
10.9%
More
EPS
$-0.1
FCF per Share
$0.3
Short interest
27.0%
Employees
769
Rev per Employee
$430.0k
Show more

Is Beauty Health Company (The) - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Beauty Health Company (The) - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Beauty Health Company (The) - Ordinary Shares - Class A forecast:

8x Hold
62%
5x Sell
38%

Analyst Opinions

13 Analysts have issued a Beauty Health Company (The) - Ordinary Shares - Class A forecast:

Hold
62%
Sell
38%

Financial data from Beauty Health Company (The) - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
310 310
15% 15%
100%
- Direct Costs 114 114
41% 41%
37%
196 196
13% 13%
63%
- Selling and Administrative Expenses 230 230
9% 9%
74%
- Research and Development Expense 4.58 4.58
48% 48%
1%
-20 -20
64% 64%
-7%
- Depreciation and Amortization 23 23
28% 28%
7%
EBIT (Operating Income) EBIT -43 -43
51% 51%
-14%
Net Profit -19 -19
77% 77%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Beauty Health Company (The) - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Beauty Health Company (The) - Ordinary Shares - Class A Stock News

Neutral
Seeking Alpha
26 days ago
The Beauty Health Company (NASDAQ:SKIN ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Marla Malcolm Beck - President, CEO & Director Michael P. Monahan - Chief Financial Officer Conference Call Participants Alec Edward Legg - Canaccord Genuity Corp., Research Division Bruce David Jackson - The Benchmark Company, LLC, Research Division Joseph Paul Federico - St...
Positive
The Motley Fool
27 days ago
Beauty Health (SKIN) Q2 Net Jumps 62%
Neutral
GlobeNewsWire
about one month ago
The Beauty Health Company will report second quarter 2025 financial results after market on August 7, 2025 and host a webcast at 4:30 p.m. ET that day.
More Beauty Health Company (The) - Ordinary Shares - Class A News

Company Profile

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Head office United States
CEO Marla Beck
Employees 769
Founded 1997
Website investors.beautyhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today